AmeriFlex Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$744K Sell
11,651
-262
-2% -$16.6K 0.26% 79
2026
Q2
$686K Sell
11,913
-76
-0.6% -$4.36K 0.28% 70
2026
Q1
$727K Buy
11,989
+1,751
+17% +$102K 0.37% 58
2025
Q4
$552K Buy
10,238
+6,171
+152% +$297K 0.29% 72
2025
Q3
$183K Buy
4,067
+2,936
+260% +$137K 0.07% 227
2025
Q2
$52.8K Sell
1,131
-8,741
-89% -$429K 0.03% 376
2025
Q1
$602K Buy
9,872
+4,409
+81% +$257K 0.25% 93
2024
Q4
$322K Buy
+5,463
New +$305K 0.15% 140

Other funds holding BMY

AmeriFlex Group's BMY Position: Q3 2026 in Review

AmeriFlex Group reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q3 2026, selling an estimated $16.6K and leaving 11,651 shares worth $744K. The position accounts for 0.26% of the portfolio, ranked #79.

AmeriFlex Group first reported a position in BMY in Q4 2024 and has held it in 8 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • AmeriFlex Group held 11,651 shares of Bristol-Myers Squibb worth $744K as of Q3 2026.
  • AmeriFlex Group sold 262 Bristol-Myers Squibb shares in Q3 2026, an estimated $16.6K.
  • Bristol-Myers Squibb made up 0.26% of AmeriFlex Group's portfolio in Q3 2026, its #79 holding.
  • AmeriFlex Group first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 8 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on AmeriFlex Group's 13F filing for Q3 2026, filed 13 Nov 2026.